| Zaima Choudhry, MD | |
|
27 Park Ave #5, Binghamton, NY 13903-1498 | |
| (607) 762-2251 | |
| Not Available |
| Full Name | Zaima Choudhry |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 27 Park Ave #5, Binghamton, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306399225 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD472420 (Pennsylvania) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 315800 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chenango Memorial Hospital | Norwich, NY | Hospital |
| United Health Services Hospitals, Inc | Binghamton, NY | Hospital |
| Lourdes Hospital | Binghamton, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Medical Associates Pc | 0345144978 | 156 |
| United Health Services Hospitals, Inc. | 5193610533 | 355 |
| Chenango Memorial Hospital Inc | 7517853633 | 93 |
News Archive
AROUND half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today (Thursday).
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.
Meanwhile, CQ HealthBeat reports that the Department of Health and Human Services is bracing for a significant number of public comments regarding the health law's essential benefits provision.
Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.
Sepsis, the syndrome of life-threatening organ dysfunction caused by infection, is a major cause of death, disability, and cost. Many studies suggest that the incidence of sepsis is increasing over time, while mortality rates are decreasing.
› Verified 8 days ago
| Entity Name | United Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013972801 PECOS PAC ID: 0345144978 Enrollment ID: O20031125000020 |
News Archive
AROUND half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today (Thursday).
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.
Meanwhile, CQ HealthBeat reports that the Department of Health and Human Services is bracing for a significant number of public comments regarding the health law's essential benefits provision.
Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.
Sepsis, the syndrome of life-threatening organ dysfunction caused by infection, is a major cause of death, disability, and cost. Many studies suggest that the incidence of sepsis is increasing over time, while mortality rates are decreasing.
› Verified 8 days ago
| Entity Name | United Health Services Hospitals, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962463851 PECOS PAC ID: 5193610533 Enrollment ID: O20040216001017 |
News Archive
AROUND half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today (Thursday).
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.
Meanwhile, CQ HealthBeat reports that the Department of Health and Human Services is bracing for a significant number of public comments regarding the health law's essential benefits provision.
Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.
Sepsis, the syndrome of life-threatening organ dysfunction caused by infection, is a major cause of death, disability, and cost. Many studies suggest that the incidence of sepsis is increasing over time, while mortality rates are decreasing.
› Verified 8 days ago
| Entity Name | Chenango Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770593956 PECOS PAC ID: 7517853633 Enrollment ID: O20040225000911 |
News Archive
AROUND half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today (Thursday).
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.
Meanwhile, CQ HealthBeat reports that the Department of Health and Human Services is bracing for a significant number of public comments regarding the health law's essential benefits provision.
Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.
Sepsis, the syndrome of life-threatening organ dysfunction caused by infection, is a major cause of death, disability, and cost. Many studies suggest that the incidence of sepsis is increasing over time, while mortality rates are decreasing.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zaima Choudhry, MD 33 Lewis Rd, 2nd Fl, Binghamton, NY 13905 Ph: (607) 770-0025 | Zaima Choudhry, MD 27 Park Ave #5, Binghamton, NY 13903-1498 Ph: (607) 762-2251 |
News Archive
AROUND half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today (Thursday).
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.
Meanwhile, CQ HealthBeat reports that the Department of Health and Human Services is bracing for a significant number of public comments regarding the health law's essential benefits provision.
Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.
Sepsis, the syndrome of life-threatening organ dysfunction caused by infection, is a major cause of death, disability, and cost. Many studies suggest that the incidence of sepsis is increasing over time, while mortality rates are decreasing.
› Verified 8 days ago
Dr. Thomas Parsley, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 161 Riverside Dr, Suite 306, Binghamton, NY 13905 Phone: 607-798-6700 Fax: 607-798-6745 | |
Matthew Pinto, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 33 Mitchell Ave, Binghamton, NY 13903 Phone: 607-762-3281 Fax: 607-762-3295 | |
Purushothaman Muthukanagaraj, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1042 Mitchell Ave # 42, Binghamton, NY 13903 Phone: 607-762-2990 | |
Ali Marhaba, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 | |
Kiran Talati, MD Nephrology Medicare: Medicare Enrolled Practice Location: 20-24 S Washington St, Binghamton, NY 13903 Phone: 607-772-6161 Fax: 607-772-6138 | |
Leslie Bank, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 | |
Dr. Stephen Francis Kucera, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3248 Dogwood Dr, Binghamton, NY 13903 Phone: 607-722-9352 |